phase readout
saveNCT03561701: A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
COMPLETEDupdated 9d ago
community read0 votes
Sponsor: Mycovia Pharmaceuticals Inc.. Phase: PHASE3. Conditions: Recurrent Vulvovaginal Candidiasis
view source ↗
comments(0)
5-min edit window · permanent after that